RxDoctor Payments Data

Carrie Pettit

Family · Raleigh, NCNPI 1053681908

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $252,225 of the $298,086 with a category attached, or 84.6%. AbbVie accounts for 94.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $89,687 and has fallen 78.9% since, to $18,907 in 2025. Among family clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$298,086in general payments, 2019–2025

Across 498 payments — averaging $598.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$281K
  • Otsuka America Pharmaceutical, Inc.$10K
  • Vanda Pharmaceuticals Inc.$7K
  • Johnson & Johnson$20

What the payments were for

  • Consulting fees$1,5081%
  • Speaking & faculty fees$252,22585%
  • Travel & lodging$39,94913%
  • Food & beverage$4,4031%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$298,086 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lamotrigine13$429
Aripiprazole13$414
Clonazepam14$90

Paid to pharmacies, not to this prescriber.

Other family in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →